Screener
Sutro Biopharma STRO Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
Based on the most recent quarter.
The source filing: Sutro Biopharma’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224170
FAQ
- What is Sutro Biopharma's current ratio?
- Sutro Biopharma (STRO) reported current ratio of 3.1× in Q1 2026.
- How has Sutro Biopharma's current ratio changed year-over-year?
- Sutro Biopharma's current ratio increased by 44.5% year-over-year, from 2.2× to 3.1×.
- What is the long-term trend for Sutro Biopharma's current ratio?
- Over 5 years (2020 to 2025), Sutro Biopharma's current ratio has grown at a -30.9% compound annual growth rate (CAGR), from 12.8× to 2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Sutro Biopharma's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude